Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Zeneca describes SAR for new asthma therapy in development

Sep. 29, 1997

Arris reports data from phase IIa asthma trial

Sep. 26, 1997

CMI-947: new 5-LO inhibitor discovered at CytoMed

Sep. 26, 1997

Synthetic studies on LAS-32521 reported

Sep. 26, 1997

Novel benzothiazolone ethanamines for airways diseases

Sep. 26, 1997

Labeling changes for Seldane products

Sep. 25, 1997

Yamanouchi develops potent and selective PDE IV inhibitors

Sep. 25, 1997

Anti-IgE MAb progresses to late-stage clinical trials in asthma

Sep. 24, 1997

Duramycin available for licensing from MoliChem Medicines

Sep. 24, 1997

Novel leukotriene antagonists from Menarini

Sep. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...